insights_auto
Outlook: 63.6% bullish·9.1% bearish
Go to analysischevron_right
LILY34:BVMF
Eli Lilly And Company BDR
R$200.61
0.00%
(0.00) 1D
Oct 2, 5:06:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
R$200.78
High
R$202.73
Low
R$198.22
Mkt. cap
1.08T
Avg. vol.
36.89K
Volume
16.70K
52-wk high
R$223.07
52-wk low
R$141.56
Shares outstanding
941.36M
No. of employees
50K
Open
R$200.78
High
R$202.73
Low
R$198.22
Mkt. cap
1.08T
Avg. vol.
36.89K
Volume
16.70K
52-wk high
R$223.07
52-wk low
R$141.56
Shares outstanding
941.36M
No. of employees
50K
News stories
From web sources and news partners
TheStreet
·
1 day ago
Eli Lilly’s Foundayo delivers diabetes surprise in late-stage study
Stocktwits
·
1 day ago
FHTX Stock Extends Sell-Off After Lilly Collaboration Ends — Wedbush Slashes Target By 80%
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websitelilly.com